Table 1.
Percent-predicted lung function following successful treatment by participant characteristics at treatment initiation.
Fig 1.
Burden of lung function defects among successfully treated TB cases.
AO—airflow obstruction, COPD—chronic obstructive pulmonary disease, RSP—restrictive spirometry pattern. Burden of lung function defects calculated as a proportion of the total sample size (n = 172).
Table 2.
Total SGRQ scores and percent-predicted lung function by lung function defect classification following successful treatment.
Fig 2.
Difference in FEV1 z-score by participant characteristics at treatment initiation.
Figure depicts point estimate and accompanying 95% confidence interval for FEV1 standardized by z-scores. Higher z-scores indicate better FEV1. Regression analysis was adjusted for age, sex, BMI, ever-smoking, duration of illness, cavitation, diabetes and smear grade. FEV1 —forced expiratory volume in the first second, BMI—body mass index, AFB—acid fast bacilli.
Fig 3.
Difference in FVC z-score by participant characteristics at treatment initiation.
Figure depicts point estimate and accompanying 95% confidence interval for FVC standardized by z-scores. Higher z-scores indicate better FVC. Regression analysis was adjusted for age, sex, BMI, ever-smoking, duration of illness, cavitation, diabetes and smear grade. FVC—forced expiratory volume, BMI—body mass index, AFB—acid fast bacilli.
Fig 4.
Difference in FEV1/FVC z-score by participant characteristics at treatment initiation.
Figure depicts point estimate and accompanying 95% confidence interval for FEV1/FVC standardized by z-scores. Lower z-scores indicate greater degree of airflow obstruction. Regression analysis was adjusted for age, sex, BMI, ever-smoking, duration of illness, cavitation, diabetes and smear grade. BMI—body mass index, AFB—acid fast bacilli.
Table 3.
Participant characteristics at treatment initiation associated with lung function defects following successful treatment.